Charlotte Catharina Teneback MD (She/Her)

Cystic Fibrosis

Associate Professor, Medicine, University of Vermont College of Medicine Director, Adult Cystic Fibrosis Program

111 Colchester AvenueMain Campus, East Pavilion , Level 5Burlington, VT 05401
Phone+1 802-847-1158
Fax+1 802-847-2444

Dr. Teneback is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Teneback's full profile Already have an account?

Summary

Charlotte Teneback, MD, is a pulmonologist based in Burlington, VT, with a subspecialty in cystic fibrosis and bronchiectasis. She completed her residency in Internal Medicine at Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital and a fellowship in Pulmonary Disease and Critical Care Medicine at the University of Vermont Medical Center, where she is currently an attending physician since 2010. Her research includes several publications focusing on cystic fibrosis-related respiratory infections and inhaled bacteriophage therapy, with notable studies published in journals such as Nature Medicine and Pediatric Pulmonology. Dr. Teneback has been involved in multiple clinical trials. She has co-edited a book on Bronchiectasis.

Education & Training

University of Vermont Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2007 - 2010
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 2004 - 2007
Medical University of South CarolinaClass of 2004

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NY State Medical License 2021 - 2026
VT State Medical License 2007 - 2026
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
CMS Meaningful Use Stage 2 Certification Beacon Cancer Registry Reporting, Epic Systems Corporation, 2013-2017

Clinical Trials

AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic Fibrosis Start of enrollment: 2017 Sep 20
Completed
Phase 3
A Phase 3 Study of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF) Start of enrollment: 2018 Jun 15
Completed
Phase 3
A Study of VX-445 Combination Therapy in CF Subjects Homozygous for F508del (F/F) Start of enrollment: 2018 Aug 03
Completed
Phase 3

Publications & Presentations

PubMed

Remodelling of cystic fibrosis respiratory microbiota in response to extended elexacaftor-tezacaftor-ivacaftor therapy.
Helen Gavillet, Lauren R Hatfield, Michelle Hardman, Ryan Marsh, Gisli G Einarsson
Microbiome. 2026-05-30
2 citations
Nontuberculous mycobacteria remodel lung microbiota in cystic fibrosis-associated respiratory infections.
Michelle Hardman, Sarah Higgi, Liam Hanson, Kristin Schutz, Matthew J Wargo
Microbiology Spectrum. 2025-09-02
58 citations
Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis.
Benjamin K Chan, Gail L Stanley, Kaitlyn E Kortright, Albert C Vill, Mrinalini Modak
Nature Medicine. 2025-05-01